ALQGC Quantum Genomics Société Anonyme
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.…
Industry Peers
BiotechnologyKey Statistics
About Quantum Genomics (EPA: ALQGC)
›
Quantum Genomics (EPA: ALQGC) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 1 employees.
The shares were at 0.0721 EUR on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0721 EUR to 0.0721 EUR, and it trades at the top of that range.
Its market capitalisation is 5.03M EUR.
Quantum Genomics reports return on equity of 362.1% and revenue down 83.3% year over year.
Its debt exceeds its cash by 2.34M EUR. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health.